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http:WHAT THIS PAPER ADDS
As far as is known, no study has speciﬁcally evaluated the methodological and reporting quality of randomised
controlled trials (RCTs) in vascular and endovascular surgery. The ﬁndings of this study are novel in vascular and
endovascular surgery which highlight the need for better compliance of clinicians, researchers, journal editors,
reviewers and the industry involved in studies to the reporting and methodological standards in future RCTs.Background: Randomised controlled trials (RCTs) are subject to bias if they lack methodological quality.
Moreover, optimal and transparent reporting of RCT ﬁndings aids their critical appraisal and interpretation.
Objectives: The aim of this study was to ascertain whether the methodological and reporting quality of RCTs in
vascular and endovascular surgery is improving.
Methods: The most recent 75 and oldest 75 RCTs published in leading journals over a 10-year period (2003e
2012) were identiﬁed. The reporting quality and methodological quality data of the old and new RCTs were
extracted and compared. The former was analysed using the Consolidated Standards of Reporting Trials
(CONSORT) statement, the latter with the Scottish Intercollegiate Guidelines Network (SIGN) checklist.
Results: Reporting quality measured by CONSORT was better in the new studies than in the old studies (0.68
[95% CI, 0.66e0.7] vs. 0.60 [95% CI, 0.58e0.62], p < .001); however, both new and old studies had similar
methodological quality measured by SIGN (0.9 [IQR 0.1] vs. .09 [IQR: 0.2], p ¼ .787). Unlike clinical items, the
methodological items of the CONSORT statement were not well reported in old and new RCTs. More trials in the
new group were endovascular related (33.33% vs. 17.33%, p ¼ .038) and industry sponsored (28% vs. 6.67%,
p ¼ .001).
Conclusions: Despite some progress, there remains room for improvement in the reporting quality of RCTs in
vascular and endovascular surgery. The methodological quality of recent RCTs is similar to that of trials performed
>10 years ago.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Randomised controlled trials (RCTs) are the gold standard to
compare the effectiveness of different interventions, if
designed, conducted, and reported appropriately.1 The
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//dx.doi.org/10.1016/j.ejvs.2015.06.114the evolution of research-informed healthcare entails that
both patients and physicians are expected to make
informed decisions based on best available evidence.2 RCTs
are subject to bias if they lack methodological quality. This,
in turn, may impair the quality of systematic reviews and
meta-analyses.3 For accurate assessment of a trial, readers
should be provided with complete, clear, and transparent
information on its methodology and ﬁndings.4
Surgical RCTs are particularly subject to bias because of
difﬁculties associated with blinding, recruitment, and
crossover problems, differential placebo effects, type II er-
rors, learning curves, poor internal and external validity, low
sample size leading to inadequately powered studies, the
logistics of investigating uncommon conditions, and
Reporting and Methodological Quality of Randomised Controlled Trials 665emergency surgery.5 Therefore, optimal reporting of surgi-
cal RCTs is extremely important in order to allow for
interpretation of potential bias.
The Consolidated Standards of Reporting Trials (CON-
SORT) statement was developed by an international group
of clinical trialists, statisticians, epidemiologists, and
biomedical editors in response to concerns about subopti-
mal reporting of RCTs.6 The CONSORT statement aims to
facilitate complete and transparent reporting of RCT ﬁnd-
ings and aid their critical appraisal and interpretation.7 The
CONSORT statement was ﬁrst published in 19968 and
revised in 20019 and 201010 to incorporate new elements.
The statement, which now consists of a 25-item checklist,10
has been supported by the World Association of Medical
Editors, the International Committee of Medical Journal
Editors, the Council of Science Editors, and a signiﬁcant
number of journals worldwide,11 and has resulted in
improvement in the overall quality of RCT reporting.12,13 In
addition to the CONSORT statement, some authors have
also suggested design and reporting standards for RCTs.14,15
Suboptimal reporting quality of RCTs in general surgery,
cardiothoracic surgery, urology, and plastic surgery has been
reported previously.5,16e18 In addition, a recent systematic
review reported inadequate compliance to the CONSORT
statement in surgical RCTs.19 Although there has been
promising evidence20 regarding improvement in the
reporting quality of surgical RCTs since the development of
the CONSORT statement, there remains much room for
improvement. To our knowledge, no study has speciﬁcally
evaluated the methodological and reporting quality of RCTs
in vascular and endovascular surgery.
In this study we aimed to compare the reporting quality,
measured by the CONSORT statement, and methodological
quality, measured by the Scottish Intercollegiate Guidelines
Network (SIGN) checklist, between old and new RCTs in
vascular and endovascular surgery published in leading
journals over a 10-year period.METHODS
Literature search strategy
Medical journals were ranked from the “surgery” and
“medicine, general, and internal” categories of journals
established by the Institute of Scientiﬁc Information’s
Journal Citation Report (ISI-JCR). The 2012 JCR Science
Edition was used. Three leading journals in vascular and
endovascular surgery, four major journals of general sur-
gery, and another four major journals in medicine with the
highest impact factor were identiﬁed and selected as the
data sources: Journal of Vascular Surgery (impact factors
2012/13: 2.88/2.98), European Journal of Vascular and
Endovascular Surgery (2.82/3.07), Journal of Endovascular
Therapy (2.70/3.59); Annals of Surgery (6.33/7.19), British
Journal of Surgery (4.84/5.21), Journal of the American
College of Surgeons (4.50/4.45), JAMA Surgery (4.10/4.30);
New England Journal of Medicine (51.66/54.42), Lancet
(39.06/39.21), Journal of the American Medical Association(29.98/30.39), and the British Medical Journal (17.22/
16.38).
All randomised controlled trials published in these jour-
nals during a 10-year period between 2003 and 2012 were
identiﬁed. Searches were performed by a clinical informa-
tion specialist (M.M.).Study selection
Titles and abstracts identiﬁed through the literature search
were screened by a single author (P.G.). The full texts of
potentially included studies were retrieved and assessed for
eligibility. The results of study selection were discussed with
the entire group.
The eligible studies were ranked based on their publica-
tion date from the oldest to the most recent. For the pur-
poses of our study, the 75 most recent studies and 75 oldest
studies were selected and grouped as “new studies” and
“old studies”, respectively.Eligibility criteria
Studies were considered eligible if (a) they were rando-
mised controlled trials, deﬁned as studies in which a
number of similar people are randomly assigned to two
(or more) groups to test a speciﬁc drug or treatment (the
deﬁnition of the National Institute for Health and Care
Excellence [NICE] was applied)21; (b) they assessed the
effects of surgical or endovascular interventions for the
treatment of extracranial carotid or vertebral artery dis-
ease, disease of the remainder of the supra-aortic vessels,
aortoiliac disease, disease of the renal and visceral vessels,
upper or lower extremity arterial disease, venous disease
of the lower limbs (including the pelvis) and the upper
limbs (including the thoracic outlet), and in vascular access
for haemodialysis; (c) they focused on the diagnosis or
screening of vascular disease affecting the aforementioned
anatomical territories; (d) they assessed medical treat-
ments for vascular disease in anatomical areas described
above; (e) they were conducted in humans; and (f) they
were published as full text articles. Pilot or phase I trials,
those reporting subgroup analyses of previously published
reports, and trials not conducted in patients, such as those
examining healthy volunteers, human cadavers, or physi-
cian training, were excluded. In cases where more than
one publication from a single trial existed, the primary
publication only was selected for data extraction and
analysis.Data extraction
An electronic dataset was created by one author (G.A.).
Additional potential items for extraction and analysis were
discussed and deﬁned in a round table forum. The database
was pilot tested in 10 randomly selected articles and
adjusted accordingly. Data extraction was undertaken by
two independent authors (Shahin H. and Shahab H.) and
checked for quality assurance by a third author (G.A.).
Table 1. Bibliomertric characteristics of included studies.
Year of publication All studiesa (%) New studiesa (%) Old studiesa (%) pb
2012 20 out of 150 (13.33) 20 out of 75 (26.67) e e
2011 22 out of 150 (14.67) 22 out of 75 (29.33) e e
2010 33 out of 150 (22.00) 33 out of 75 (44.00) e e
2005 28 out of 150 (18.67) e 28 out of 75 (37.33) e
2004 28 out of 150 (18.67) e 28 out of 75 (37.33) e
2003 19 out of 150 (12.67) e 19 out of 75 (25.33) e
Journal
Vascular surgery journals 115 out of 150 (76.67) 61 out of 75 (81.33) 54 out of 75 (72) .247
Non-vascular surgery journals 35 out of 150 (23.33) 14 out of 75 (18.67) 21 out of 75 (28) .247
Subject area
Arterial related (%) 98 out of 150 (65.33) 44 out of 75 (58.67) 54 out of 75 (72.00) .122
Venous related (%) 43 out of 150 (28.67) 27 out of 75 (36.00) 16 out of 75 (21.33) .070
Vascular access (%) 9 out of 150 (6.00) 4 out of 75 (5.33) 5 out of 75 (6.67) 1.000
Endovascular-related study (%) 38 out of 150 (25.33) 25 out of 75 (33.33) 13 out of 75 (17.33) .038
Title reporting study ﬁndings (%) 18 out of 150 (12) 7 out of 75 (9.33) 11 out of 75 (14.67) .452
Study design reported in title (%) 118 out of 150 (78.67) 58 out of 75 (77.33) 60 out of 75 (80) .842
Number of pages (IQR) 7 (3) 8 (2) 7 (3) .121
Number of references (IQR) 25.5 (13) 27 (14) 25 (13) .374
Continent (%)
Europe 121 out of 150 (8.67) 62 out of 75 (82.67) 59 out of 75 (78.67) .680
North America 24 out of 150 (16.00) 10 out of 75 (13.33) 14 out of 75 (18.67) .505
Asia 1 out of 150 (.67) 1 out of 75 (1.33) 0 1.000
Australia 3 out of 150 (2.00) 2 out of 75 (2.67) 1 out of 75 (1.33) 1.000
Africa 0 0 0 1.000
South America 1 out of 150 (.67) 0 1 out of 75 (1.33) 1.000
Number of institutions (IQR) 1 (3) 1 (3) 1 (3) .803
International collaboration (%) 15 out of 150 (10) 8 out of 75 (1.67) 7 out of 75 (9.33) 1.000
Open access (%) 118 out of 150 (78.67) 55 out of 75 (73.33) 63 out of 75 (84) .162
External funding (%) 87 out of 150 (58) 43 out of 75 (57.33) 44 out of 75 (58.67) 1.000
Industry sponsored (%) 26 out of 150 (17.33) 21 out of 75 (28) 5 out of 75 (6.67) .001
Sample size (IQR) 103 (142) 118 (140) 100 (223) .651
Positive primary outcome (%) 111 out of 150 (74) 55 out of 75 (73.33) 56 out of 75 (74.67) 1.000
IQR: interquartile range.
a Median for continuous data and proportions for binomial data.
b ManneWhitney test and Fisher exact test were used for comparison of medians and proportions, respectively (conﬁdence level: 95%).
666 S. Hajibandeh et al.Reporting quality data
Compliance of the selected trials with the CONSORT state-
ment, was assessed by two independent authors (Shahin H.
and Shahab H.). The most recent version of the CONSORT
statement,4 published in 2010, was used. This comprises a
25-item checklist, investigating the trial design, analysis, and
interpretation. The CONSORT statement was used in
conjunction with the CONSORT Explanation and Elaboration
Document. Each item of the CONSORT checklist was
answered with “yes” or “no”, with each yes earning 1 point,
for a maximum of 25 points. An overall reporting quality
score was calculated for each study, by dividing the score
achieved by the maximum possible score.
Methodological quality data
The methodological quality of the selected trials was
appraised by two independent authors (Shahin H. and
Shahab H.) using the SIGN checklist for randomised
controlled trials.22 This tool consists of two sections: section
1 comprises 10 questions and assesses the internal validity
of the trials, whereas section 2 provides an overallassessment statement of the study. Each question in section
1 is answered with “yes”, “no”, or “can’t say”. Additionally, in
section 2, the assessor grades the study as “high quality
(þþ)”, “acceptable (þ)”, or “unacceptable e reject (0)”. The
Notes on Methodology Checklist document was used in
conjunction with the SIGN appraisal tool. For each of the
questions answered with “yes”, 1 point was achieved,
whereas no points were earned for questions answered
with “no” or “can’t say”. The maximum score possible was
10, and an overall methodological quality score was calcu-
lated by dividing the score achieved by the maximum score.Statistical analysis
Statistical analyses were performed using Minitab 17
(Minitab 17.1.0). Categorical variables using proportions,
continuous variables using the mean, and non-parametric
data using the median were analysed. The Fisher exact
test was used to compare proportions, the two-sample t-
test to compare means, and the ManneWhitney test to
compare medians. The 95% conﬁdence level was used to
indicate statistical signiﬁcance in all comparisons.
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Figure 1. Comparison of CONSORT score between new and old studies.
Reporting and Methodological Quality of Randomised Controlled Trials 667RESULTS
A total of 150 randomised trials were included, of which 75
were grouped as new studies and 75 were grouped as old
studies. Among the new studies, 26.67% were published in
2012, 29.33% in 2011, and 44% in 2010. Among the old
studies, 37.33% were published in 2005, 37.33% in 2004,
and 25.33% in 2003. There was no signiﬁcant difference
between the new and old studies in the bibliometric vari-
ables (Table 1). More trials in the new group were endo-
vascular related (33.33% vs. 17.33, p ¼ .038). Moreover, the
new studies were more frequently sponsored by industry
(28% vs. 6.67%, p ¼ .001).Reporting quality data
Reporting quality measured by CONSORT was better in the
new studies. The mean overall CONSORT scores of the new
and old studies were 0.68 (95% CI, 0.66e0.7) and 0.60 (95%
CI, 0.58e0.62), respectively, (p < .001). In terms of indi-
vidual CONSORT items, the new studies scored better than
the old studies in the following items: “settings and loca-
tions where the data were collected” (75% vs. 52%,
p ¼ .004); “type of randomisation and details of any re-
striction” (59% vs. 39%, p ¼ .022); “who generated the
random allocation sequence, who enrolled participants, and
who assigned participants to interventions” (19% vs. 5%,
p ¼ .022); “dates deﬁning the periods of recruitment and
follow-up” (80% vs. 63%, p ¼ .020); “a table showing
baseline demographic and clinical characteristics for each
group” (97% vs. 85%, p ¼ .01); “registration number and
name of trial registry” (36% vs. 0%, p < .001); “sources of
funding and other support (such as supply of drugs), role offunders” (100 vs. 59%, p < .001); and “for binary outcomes,
presentation of both absolute and relative effect sizes is
recommended” (28% vs. 13%, p ¼ .042) (Fig. 1).
Methodological quality data
Both new and old studies had similar methodological
quality measured by SIGN. There was no statistically sig-
niﬁcant difference in the median overall SIGN score be-
tween the new and old studies (0.9 [IQR: 0.1] vs. 0.9 [IQR:
0.2], p ¼ .787). Moreover, the scores for each SIGN item did
not differ signiﬁcantly between two groups (Fig. 2). Both old
and new studies scored poorly in terms of allocation
concealment (73% vs. 69%), blinding (39% vs. 44%), inten-
tion to treat analysis (47% vs. 40%), and comparability of
results in multicentre trials (45% vs. 43%). In terms of
minimising bias, 81.33% of the new studies and 78.67% of
the old studies were judged as high quality (p ¼ .839);
14.67% and 16.00% as acceptable (p ¼ 1.000); and 4.00%
and 5.33% as unacceptable-reject (p ¼ 1.000).
DISCUSSION
Although compliance to the CONSORT statement has
improved the reporting quality of RCTs, suboptimal
reporting of RCTs remains a problem. The challenging na-
ture of conducting a surgical RCT and its higher subjection
to bias highlight the importance of complete and trans-
parent reporting of a surgical RCT in order to enable readers
to interpret bias while analysing the study ﬁndings.
Our analysis of 150 trials demonstrated that the reporting
quality of RCTs in vascular and endovascular surgery
measured by the CONSORT statement has improved signiﬁ-
cantly over recent years. This improvement in reporting
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
Th
e 
st
ud
y 
ad
dr
es
se
s a
n 
ap
pr
op
ria
te
 a
nd
 c
le
ar
ly
 
fo
cu
se
d 
qu
es
tio
n 
Th
e 
as
si
gn
m
en
t o
f s
ub
je
ct
s t
o 
tre
at
m
en
t g
ro
up
s i
s 
ra
nd
om
is
ed
 
A
n 
ad
eq
ua
te
 c
on
ce
al
m
en
t m
et
ho
d 
is
 u
se
d 
Su
bj
ec
ts
 a
nd
 in
ve
st
ig
at
or
s a
re
 k
ep
t ‘
bl
in
d’
 a
bo
ut
 
tre
at
m
en
t a
llo
ca
tio
n 
Th
e 
tre
at
m
en
t a
nd
 c
on
tro
l g
ro
up
s a
re
 si
m
ila
r a
t t
he
 
st
ar
t o
f t
he
 tr
ia
l 
Th
e 
on
ly
 d
iff
er
en
ce
 b
et
w
ee
n 
gr
ou
ps
 is
 th
e 
tre
at
m
en
t 
un
de
r i
nv
es
tig
at
io
n 
A
ll 
re
le
va
nt
 o
ut
co
m
es
 a
re
 m
ea
su
re
d 
in
 a
 st
an
da
rd
, 
va
lid
 a
nd
 re
lia
bl
e 
w
ay
 
W
ha
t p
er
ce
nt
ag
e 
of
 th
e 
in
di
vi
du
al
s o
r c
lu
st
er
s 
re
cr
ui
te
d 
in
to
 e
ac
h 
tre
at
m
en
t a
rm
 o
f t
he
 st
ud
y 
dr
op
pe
d 
ou
t b
ef
or
e 
th
e 
st
ud
y 
w
as
 c
om
pl
et
ed
? 
A
ll 
th
e 
su
bj
ec
ts
 a
re
 a
na
ly
se
d 
in
 th
e 
gr
ou
ps
 to
 w
hi
ch
 
th
ey
 w
er
e 
ra
nd
om
ly
 a
llo
ca
te
d 
(o
fte
n 
re
fe
rr
ed
 to
 a
s 
in
te
nt
io
n 
to
 tr
ea
t a
na
ly
si
s)
 
W
he
re
 th
e 
st
ud
y 
is
 c
ar
rie
d 
ou
t a
t m
or
e 
th
an
 o
ne
 si
te
, 
re
su
lts
 a
re
 c
om
pa
ra
bl
e 
fo
r a
ll 
si
te
s 
H
ig
h 
qu
al
ity
 
A
cc
ep
ta
bl
e 
U
na
cc
ep
ta
bl
e-
re
je
ct
  
%
 o
f s
tu
di
es
 sc
or
ed
 fo
r 
 e
ac
h 
 S
IG
N
 it
em
 
New Studies 
Old studies 
Figure 2. Comparison of SIGN score between new and old studies.
668 S. Hajibandeh et al.quality suggests a promising trend inminimising the potential
for overestimation of treatment effect and erroneous con-
clusions in vascular and endovascular surgery RCTs.
The mean overall CONSORT score of both groups (old and
new studies) in our study was higher than the mean scores
reported by other studies in other surgical disciplines. Adie
et al.18 investigated the CONSORT compliance in 150 sur-
gical RCTs and reported a mean adjusted CONSORT score of
0.55, whereas in this study the mean score in the new and
old studies was 0.68 and 0.60, respectively. Moreover, Agha
et al.5 reported mean CONSORT scores of 0.50 and 0.51 in
urological RCTs and in non-urological surgical RCTs,
respectively, which are lower than the mean scores in the
present study. In the Agha et al. study, of 74 non-urological
RCTs 15 were vascular RCTs, having a mean CONSORT score
of 0.54. Furthermore, in another study, Agha et al.18
demonstrated suboptimal reporting quality of 57 plastic
surgery RCTs with a median CONSORT score of 0.50.
Although this suggests better compliance to the CONSORT
statement in the RCTs included in the present study, it
should be taken into account the most recent version of the
CONSORT statement containing a 25 item-checklist has
been used, whereas other studies used the older version
consisting of a 22 item-checklist.
Although there is an overall improvement in the report-
ing quality of vascular and endovascular RCTs, some CON-
SORT items are still poorly reported. This includes
information about changes to study methods or outcomes
after trial commencement; interim analyses and stopping
guidelines; randomisation sequence generation; blinding;
methods for additional analyses; presentation of both ab-
solute and relative effect sizes; trial registration andprotocol. This ﬁnding, which has been consistent among old
and new RCTs in this study, supports the argument that
clinical aspects of reporting are more commonly considered
than methodological aspects by reporting authors.23
Despite signiﬁcant improvement in reporting quality of
vascular and endovascular RCTs, no signiﬁcant difference in
methodological quality between new and old RCTs was
found. The proportion of high-quality RCTs in the new
studies was higher than that in the old studies but this
difference did not reach signiﬁcance (p ¼ .839).
It has been reported that allocation concealment, blinding,
and attrition analysis, which have signiﬁcant impact on meth-
odological quality of RCTs, are poorly reported in most tri-
als.24,25 The ﬁndings support this argument as both old and
new studies did not score adequately for these items. The
possible explanation for this could beeither these items are not
actually addressed appropriately within the study or they are
not reported in detail in the corresponding published paper.
Undoubtedly, reporting of RCTs can provide clues on their
methodological quality since the assessment of the meth-
odological quality of a RCT is closely associated with the
quality of reporting.24 However, a clear distinction should be
made between these two items. Huwiler-Muntener et al.24
investigated the relationship between reporting quality and
methodological quality of 60 RCTs and found that similar
quality of reporting may hide important differences in
methodological quality, as well-conducted trials may be re-
ported badly. Similarly, Soares et al.26 demonstrated that the
methodological quality of 56 RCTs was better than their
reporting quality. As an example, they showed that adequate
allocation concealment was achieved in all included RCTs but
reported in only 42% of papers.
Reporting and Methodological Quality of Randomised Controlled Trials 669The new RCTs in this study were sponsored by industry
more frequently than the old studies. This difference may
be due to either an increase in industry funding or a
reduction in other sources of sponsorship in recent years.
We did not analyse the association between industry
sponsoring and reporting or methodological quality of trials
was not analysed. An association between industry funding
and better reporting quality has been reported by some
authors.23,27,28 Whether industry sponsoring is associated
with better trial quality or whether the better reporting
quality of RCTs achieved as a result of industry funding
outweighs the publication bias associated with industry
sponsoring remains an interesting subject that is beyond
the scope of our study and requires further exploration. In
this study, more trials in the new group were endovascular
related. The advent of minimally invasive surgery, techno-
logical achievements, and evolution of techniques and
therapies may explain the difference in the proportion of
endovascular-related trials between old and new RCTs.29
In order to achieve high quality of reporting and meth-
odology in RCTs, not only the authors but also journal ed-
itors and reviewers have crucial roles. The researchers need
to ensure that they design, conduct, and report their study
in line with methodological and reporting standards.
Moreover, journal editors and reviewers as “Gate keepers”
for published materials should only allow publication of
RCTs that are compliant to the methodological and
reporting standards. This can be facilitated by recom-
mending appropriate methodological and reporting quality
assessment tools and checklists as instructions for authors.
This study has some limitations. Only the oldest 75 and
the most recent 75 RCTs published during a 10-year period
were included. In addition, only journals with the highest
impact factors were considered. It was assumed that each
reporting or methodological item has equal impact on the
overall quality of each trial; therefore, a maximum score of
1 was allocated to each item. However, some items may
have greater impact than others; therefore, the overall
reporting or methodological quality of each trial may have
been over- or underestimated. This method, therefore, is at
risk of some selection bias. Although two independent au-
thors were involved in data extraction and quality assess-
ment of the included studies, there is always a possibility
for measurement errors, as scoring of some items in the
CONSORT and SIGN checklists are somewhat subjective.CONCLUSIONS
The reporting quality of RCTs in vascular and endovascular
surgery has improved signiﬁcantly since the development of
the CONSORT statement. Unlike clinical items, the meth-
odological items of the CONSORT statement are not well
reported; therefore, there remains room for improvement
in the reporting quality of RCTs in vascular and endovascular
surgery. The methodological quality of RCTs on vascular and
endovascular surgery remains unchanged over a 10-year
period. Future RCTs should particularly focus on improve-
ment in allocation concealment, blinding, and intention totreat analysis in their methodology and reporting. These are
novel ﬁndings in vascular and endovascular surgery that
highlight the need for better compliance of clinicians, re-
searchers, journal editors, and reviewers to the reporting
and methodological standards in future RCTs.
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